EP Patent

EP1698623A4 — 4- (3-CHLORO-4- (CYCLOPROPYLAMINOCARBONYL) AMINO-PHENOXY) -7-METHOXY-6-QUINOLINECARBOXAMIDE SALT CRYSTALS OR THE SOLVATE THEREOF, AND PROCESS FOR PRODUCING THE SAME

Assigned to Eisai R&D Management Co Ltd · Expires 2009-05-13 · 17y expired

What this patent protects

Crystals of the hydrochloride, hydrobromide, p-toluenesulfonate, sulfate, methanesulfonate, or ethanesulfonate of 4-(3-chloro-4-(cyclopropylamino-carbonyl)aminophenoxy)-7-methoxy-6-quinolinecarboxamide or crystals of a solvate of any of these.

USPTO Abstract

Crystals of the hydrochloride, hydrobromide, p-toluenesulfonate, sulfate, methanesulfonate, or ethanesulfonate of 4-(3-chloro-4-(cyclopropylamino-carbonyl)aminophenoxy)-7-methoxy-6-quinolinecarboxamide or crystals of a solvate of any of these.

Drugs covered by this patent

Patent Metadata

Patent number
EP1698623A4
Jurisdiction
EP
Classification
—
Expires
2009-05-13
Drug substance claim
No
Drug product claim
No
Assignee
Eisai R&D Management Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.